Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naldemedine for prevention of recurrent acute pancreatitis attacks
2021-000069-34Phase 2Completed
- Sponsor
- Mech-Sense
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute pancreatitis (AP) comparing Naldemedine arm with Placebo arm (2 arms). Primary endpoint: Primary: Difference in number of acute pancreatitis attacks. Started Oct 2021; status: completed.
02
Drugs
naldemedine
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on 2021-000069-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000069-34.